Literature DB >> 22805187

Desquamative interstitial pneumonia may progress to lung fibrosis as characterized radiologically.

Yoshinori Kawabata1, Tamiko Takemura, Akira Hebisawa, Yutaka Sugita, Takashi Ogura, Sonoko Nagai, Fumikazu Sakai, Tetsu Kanauchi, Thomas V Colby.   

Abstract

BACKGROUND AND
OBJECTIVE: In some patients, desquamative interstitial pneumonia may progress to lung fibrosis. The aim of this study was to assess the long-term radiological follow-up results in patients with desquamative interstitial pneumonia.
METHODS: Among 75 patients suspected of having desquamative interstitial pneumonia, 31 who fulfilled the criteria were included in this study. Clinical characteristics at presentation, responses to treatment and long-term follow-up were evaluated.
RESULTS: The 31 patients were predominantly males (94%), and the mean age was 55 years; 93% (28/30) had a history of smoking. The clinical findings included high serum levels of lactate dehydrogenase and immunoglobulin G. Bronchoalveolar lavage (26 patients, 84% of cases) frequently showed an increased percentage of eosinophils (mean 17%). Computed tomography (CT) or high resolution (HR) CT at presentation showed ground glass opacities and/or consolidation in all patients, with one third of patients also showing thin-walled cysts within the ground glass opacities. There was no honeycombing on CT or HRCT scans at presentation. Corticosteroid therapy was effective early in the course of the disease; long-term follow-up (mean 99 months) of 31 patients showed only one death due to progression of the disease, but long-term follow-up of 14 patients (mean 125 months) by HRCT showed the development of new thin-walled cysts and honeycombing in five and lung cancer in four patients, respectively.
CONCLUSIONS: In a proportion of patients, desquamative interstitial pneumonia may progress to lung fibrosis with honeycombing on HRCT, despite therapy.
© 2012 The Authors. Respirology © 2012 Asian Pacific Society of Respirology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22805187     DOI: 10.1111/j.1440-1843.2012.02226.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  6 in total

1.  [Interstitial lung diseases (ILD) in smokers: spectrum in high resolution computed tomography (HRCT)].

Authors:  K Marten-Engelke
Journal:  Radiologe       Date:  2013-09       Impact factor: 0.635

2.  Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner Society.

Authors:  Hiroto Hatabu; Gary M Hunninghake; Luca Richeldi; Kevin K Brown; Athol U Wells; Martine Remy-Jardin; Johny Verschakelen; Andrew G Nicholson; Mary B Beasley; David C Christiani; Raúl San José Estépar; Joon Beom Seo; Takeshi Johkoh; Nicola Sverzellati; Christopher J Ryerson; R Graham Barr; Jin Mo Goo; John H M Austin; Charles A Powell; Kyung Soo Lee; Yoshikazu Inoue; David A Lynch
Journal:  Lancet Respir Med       Date:  2020-07       Impact factor: 30.700

3.  CT findings associated with survival in chronic hypersensitivity pneumonitis.

Authors:  Jonathan H Chung; Steven M Montner; Ayodeji Adegunsoye; Justin M Oldham; Aliya N Husain; Rekha Vij; Imre Noth; Mary E Strek
Journal:  Eur Radiol       Date:  2017-07-07       Impact factor: 5.315

Review 4.  Pneumocyte injury and ubiquitin-positive pneumocytes in interstitial lung diseases.

Authors:  Tsutomu Yamada; Yoshinori Kawabata
Journal:  Histopathology       Date:  2014-10-30       Impact factor: 5.087

5.  Improvement in idiopathic nonspecific interstitial pneumonia after smoking cessation.

Authors:  Tsutomu Shinohara; Naoki Kadota; Hiroyuki Hino; Keishi Naruse; Yuji Ohtsuki; Fumitaka Ogushi
Journal:  Respir Med Case Rep       Date:  2014-11-22

Review 6.  Overlaps and uncertainties of smoking-related idiopathic interstitial pneumonias.

Authors:  So Hyeon Bak; Ho Yun Lee
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-11-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.